Inovio Pharmaceuticals Inc. (INO), one of the key players in the race to develop a COVID-19 vaccine, has revealed promising data from a preclinical study of INO-4800, its DNA vaccine candidate against the novel coronavirus SARS-CoV-2, which causes COVID-19.
from RTT - Biotech https://ift.tt/2WLQHIA
via IFTTT
No comments:
Post a Comment